2-羟基-5-\ { \ { 4-[（2-吡啶氨基）磺酰基]苯基}偶氮}苯甲酸

产品名称：

599-79-1
Sulfasalazine
2-Hydroxy-5-{{4-[(2-pyridinylamino)sulfonyl]phenyl}azo}benzoic acid
5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid
Salicylazosulfapyridine
柳氮磺胺吡啶
2-羟基-5-\ { \ { 4-[（2-吡啶氨基）磺酰基]苯基}偶氮}苯甲酸
5-[对-(2-吡啶胺磺酰基)苯]偶氮水杨酸

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 250 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₈H₁₄N₄O₅S
分子量	398.39
Beilstein	356241
MDL编号	MFCD00057363
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	BP
mp	260-265 ℃ (dec.) (lit.)
格式	neat
储存温度	2-8℃
SMILES string	OC(=O)c1cc(ccc1O)\N=N\c2ccc(cc2)S(=O)(=O)Nc3ccccn3
InChI	1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+
InChI key	NCEXYHBECQHGNR-QZQOTICOSA-N
Gene Information	human ... ALOX5(240), PTGS1(5742), PTGS2(5743)

安全信息

象形图
警示用语：	Danger
危险声明	H317 - H334
预防措施声明	P261 - P280 - P284 - P304 + P340 - P333 + P313 - P342 + P311
危险分类	Resp. Sens. 1 - Skin Sens. 1
储存分类代码	13 - Non Combustible Solids
WGK	WGK 2
闪点(F)	Not applicable
闪点(C)	Not applicable